ABSTRACT
Exclusive breastfeeding is recommended for the first six months of life, but many infants receive pumped milk, formula, donor human milk, or other nutritional sources during this critical period. Substantive evidence shows early nutrition influences development of the microbiome and immune system, affecting lifelong health. However, the underlying mechanisms are unclear and the nuances of human milk feeding are rarely considered. This review synthesizes evidence from human studies and model systems to discuss the impact of different nutritional sources on co-development of the gut microbiome, antigen tolerance, and immunity. We highlight two key mechanisms: epigenetics and the so-called “weaning reaction”. Collectively, this evidence highlights i) the fundamental role of parents’ own milk, fed directly at the breast, as a dynamic and personalized nutrition source that drives developmental programming, and ii) the deficiencies of alternative nutritional sources and priority research areas for improving these alternatives when direct breastfeeding is not possible.
Plain Language Summary
Before they begin eating solid foods, infants may be fed a variety of nutritional sources such as breast milk (“parent’s own milk”, fed directly at the breast or pumped and fed from a bottle), commercial infant formula, or sterilized “donor human milk” from a certified milk bank. Early nutrition affects the infant’s gut microbiome (bacteria living in the intestinal tract), development of their immune system, and their health throughout life. However, it is unclear how different forms of early nutrition affect these important processes. Parent’s own milk contains compounds that support gut microbes and stimulate development of the infant immune system, changing over time to meet infant needs. For many of these compounds, donor human milk contains a lesser amount, and formula contains even less – or none at all. Some compounds are also affected by pumping and storing parents’ own milk. This review highlights how differences among these nutritional sources influence gene expression and gut development to shape the infant microbiome and immune system. Current evidence shows that parent’s own milk, fed at the breast, offers unique benefits that are not replicated by other forms of early nutrition. This review also outlines how early life nutrition research can help us understand human development and develop new ways to provide the best possible start to life for all infants.
Abbreviations
POM | = | parent’s own milk |
Ig | = | immunoglobulin |
HMO | = | human milk oligosaccharide |
NEC | = | necrotizing enterocolitis |
DPOM | = | direct parent’s own milk |
EPOM | = | expressed parent’s own milk |
DHM | = | donor human milk |
TGF | = | transforming growth factor |
IL | = | interleukin |
IGF | = | insulin-like growth factor |
EGF | = | epithelial growth factor |
GCSF | = | granulocyte colony-stimulating factor |
IBD | = | inflammatory bowel disease |
TNF-α | = | tumor necrosis factor alpha |
TLR | = | toll like receptor |
NF-κB | = | nuclear factor-κB |
RORγt+ Treg | = | RAR-related orphan receptor gamma expressing regulatory T cell |
FOS | = | fructooligosaccharide |
GOS | = | galactooligosaccharides |
FA | = | fatty acid |
Disclosure statement
M.B.A. receives research funding from the Canadian Institutes of Health Research, US National Institutes of Health, Research Manitoba, the Canada Foundation for Innovation, the Bill and Melinda Gates Foundation, the Manitoba Children’s Hospital Foundation, CIFAR, and the Garfield Weston Foundation. She has previously received funding from Prolacta Biosciences. She has contributed without remuneration to online courses on breast milk and the infant microbiome produced by Microbiome Courses. She serves in a volunteer capacity for the International Society for Research on Human Milk and Lactation and as a member of the US Canada Joint Human Milk Initiative. She has consulted for DSM Nutritional Products and serves on the Scientific Advisory Boards of TinyHealth and MalaikaVx.